Fortress Biotech, Inc. Loss Contingency, Damages Sought, Value
Fortress Biotech, Inc. (FBIO) reported Loss Contingency, Damages Sought, Value of $3.30 million for the 0-month period ending 2018-07-12, per its 10-K filed 2019-03-18.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyDamagesSoughtValue · last filed 2020-03-16
- 2018-07-12: Loss Contingency, Damages Sought, Value 0 month $3.30M; Loss Contingency, Damages Sought, Value $3.30M.
| Period end | Loss Contingency, Damages Sought, Value 0 month | Loss Contingency, Damages Sought, Value |
|---|---|---|
| 2018-07-12 | $3.30M 10-K · filed 2019-03-18 | $3.30M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |